fbpx
Civil Plaintiff

States Reach $2.4B Deal Over Marketing and Safety Practices of Generic Opioids

A former opioid manufacturer has agreed in principle to pay up to $2.4 billion in a deal with a dozen states over its marketing and product safety practices, state attorneys general announced Friday.

The company, Allergan, is now part of AbbVie but sold its generics division Actavis, including its opioid products, to Teva Pharmaceuticals six years ago. Under the settlement, payments will be made to state and local governments, Pennsylvania Attorney General Josh Shapiro said.

The agreement means pharma companies have consented to pay more than $40 billion to settle opioid crisis claims regarding manufacturers and distributors, The Associated Press has found.

Read the source article at CBS News

    Leave a Review or Comment

    Your email address will not be published.

    Back to top button